tiprankstipranks
Adlai Nortye Ltd. Sponsored ADR (ANL)
NASDAQ:ANL
US Market

Compare Adlai Nortye Ltd. Sponsored ADR (ANL) vs. Competitors

39 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Adlai Nortye Ltd. Sponsored ADR
$12.00
$442.80M
506.06%
3 Buy
0 Hold
0 Sell
Strong Buy
Veru
$2.43
$39.00M
-2.04
-55.08%
2 Buy
0 Hold
0 Sell
Moderate Buy
Aligos Therapeutics
$7.94
$49.13M
-1.22
57.85%
3 Buy
0 Hold
0 Sell
Strong Buy
Genenta Science SpA Sponsored ADR
$1.45
$15.91M
-2.51
-82.41%
Acrivon Therapeutics, Inc.
$1.55
$60.05M
-1.19
-3.73%
3 Buy
0 Hold
0 Sell
Strong Buy
Radiopharm Theranostics Limited Sponsored ADR
$4.67
$52.68M
-1.28
16.75%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ANL
Adlai Nortye Ltd. Sponsored ADR
12.00
9.92
476.92%
VERU
Veru
2.43
-3.02
-55.41%
ALGS
Aligos Therapeutics
7.94
3.33
72.23%
GNTA
Genenta Science SpA Sponsored ADR
0.68
-3.11
-82.08%
ACRV
Acrivon Therapeutics, Inc.
1.55
0.05
3.33%
RADX
Radiopharm Theranostics Limited Sponsored ADR
4.67
0.19
4.24%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts